Medten EU ApSAktiv
Økonomiske nøgletal
Nøgletal
2025Balancens sammensætning
Selskabsskat
indkomstår 2024Kilde: Skattestyrelsens offentlige skattelister for selskaber. Beregnet skat for indkomståret; kan være lavere end 22 % af indkomsten, fx ved skat betalt i udlandet. sktst.dk
Regnskabstal2023–2025
| 2023 | 2024 | 2025 | |
|---|---|---|---|
| Balance — aktiver | |||
| Likvide beholdninger | 689.273 | 1.949.244 | 2.522.427 |
| Omsætningsaktiver i alt | 1.952.787 | 3.968.933 | 5.251.667 |
| Anlægsaktiver i alt | 56.947 | 42.915 | 28.883 |
| Aktiver i alt | 2.009.734 | 4.011.848 | 5.280.550 |
| Balance — passiver | |||
| Kortfristede gældsforpligtelser | 3.226.003 | 6.462.907 | 6.860.382 |
| Langfristede gældsforpligtelser | — | — | — |
| Gældsforpligtelser i alt | 3.226.003 | 6.462.907 | 6.860.382 |
| Selskabskapital | 40.000 | 40.000 | 40.000 |
| Overført resultat | -1.256.269 | -2.491.059 | -1.619.832 |
| Årets resultat | -1.256.269 | -1.234.790 | 871.227 |
| Egenkapital i alt | -1.216.269 | -2.451.059 | -1.579.832 |
| Resultatopgørelse | |||
| Bruttofortjeneste | -568.382 | -608.748 | 1.011.509 |
| Resultat af primær drift | -1.263.301 | -1.239.694 | 311.975 |
| EBITDA | -1.250.117 | -1.225.662 | 326.007 |
| Resultat før skat | — | — | 871.227 |
| Årets resultat | -1.256.269 | -1.234.790 | 871.227 |
| Personaleomkostninger | 681.735 | 616.914 | 685.502 |
| Af- og nedskrivninger | 13.184 | 14.032 | 14.032 |
| Andre nøgletal | |||
| Ansatte | 2 | 1 | 1 |
En streg (—) betyder, at der ikke er indsendt årsrapport, eller at posten ikke fremgår af den; 0 er et nul angivet i årsrapporten.
Om virksomheden
Årsrapport 2025Business reviewThe company's purpose is sale of medical equipment and any related business at the discretion of the management.
Financial review The company's income statement for the year ended 31 December 2025 shows a profit of DKK 871.227, and the balance sheet at 31 December 2025 shows negative equity of DKK 1.579.832.A second year of loss is not concerning for the management as we see significant growth in sales and know this will lead to an eventual yearly outcome of profit and a positive balance sheet (most probably in our 4th year in business, 2026). Setting up a large-scale sales office and distribution center in Europe is not an enterprise where short-term profitability is expected. With our experience in following a similar business plan in the US market, the management expects (and have planned for) at least 3 years of losses before reaching the point of profitability through increased sales. Based on the current Medten EU ApS business plan and the progress we have made over the last 12 months the management team feels confident that our company will remain viable over the next fiscal year. Even with some unexpected challenges during this second economic year (mainly a legal dispute in Germany) our operation has remained steady and our growth has been continuous. Within 5 years we expect Medten EU ApS to be a firmly established and well respected company within the European Medical Equipment community. We are considering to eventually add repair services to our operation (possibly in 2026) as we have done in the US market through Medten USA Inc. in 2024. This brings the potential for us to
Uddrag af ledelsesberetningen i den seneste årsrapport.